Related Experiment Video
Updated: Jun 20, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation
Rosario Amato1, Lucia D'Antona, Giovanni Porciatti
1Department of Experimental and clinical Medicine G. Salvatore, Faculty of Medicine, University Magna Graecia at Catanzaro, Catanzaro, Italy.
Abstract:
Serum and glucocorticoid regulated kinase 1 (Sgk1) is a serine-threonine kinase that is activated by serum, steroids, insulin, vasopressin, and interleukin 2 at the transcriptional and post-translational levels. Sgk1 is also important in transduction of growth factors and steroid-dependent survival signals and may have a role in the development of resistance to cancer chemotherapy. In the present paper, we demonstrate that Sgk1 activates MDM2-dependent p53 ubiquitylation. The results were obtained in RKO cells and other cell lines by Sgk1-specific RNA silencing and were corroborated in an original mouse model as well as in transiently and in stably transfected HeLa cells expressing wild-type or dominant negative Sgk1 mutant. Sgk1 contributes to cell survival, cell-cycle progression, and epithelial de-differentiation. We also show that the effects of Sgk1 on the clonogenic potential of different cancer cells depend on the expression of wild-type p53. Since transcription of Sgk1 is activated by p53, we propose a finely tuned feedback model where Sgk1 down-regulates the expression of p53 by enhancing its mono- and polyubiquitylation.
Insights
Serum and glucocorticoid regulated kinase 1 (Sgk1) enhances p53 ubiquitylation, promoting cell survival and cancer chemotherapy resistance. This kinase activity, regulated by p53, suggests a feedback loop influencing tumor progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Serum and glucocorticoid regulated kinase 1 (Sgk1) is a key kinase involved in cell survival and steroid signaling.
- Sgk1 activation is linked to growth factor signaling and may contribute to cancer chemotherapy resistance.
- The interplay between Sgk1 and the tumor suppressor p53 is not fully understood.
Purpose of the Study:
- To investigate the role of Sgk1 in p53 ubiquitylation and its downstream effects.
- To elucidate the functional relationship between Sgk1 and p53 in cancer cells.
- To propose a regulatory model for Sgk1 and p53 interaction.
Main Methods:
- Sgk1-specific RNA silencing in RKO and other cell lines.
- Experiments in a mouse model and transfected HeLa cells (wild-type and dominant-negative Sgk1).
- Analysis of p53 ubiquitylation, cell survival, cell-cycle progression, and clonogenic potential.
Main Results:
- Sgk1 was demonstrated to activate MDM2-dependent p53 ubiquitylation.
- Sgk1 influences cell survival, cell-cycle progression, and epithelial de-differentiation.
- The impact of Sgk1 on cancer cell clonogenic potential is dependent on wild-type p53 expression.
- A feedback loop was proposed where Sgk1 down-regulates p53 via ubiquitylation.
Conclusions:
- Sgk1 plays a critical role in regulating p53 stability and function through ubiquitylation.
- Sgk1 contributes to cancer cell survival and proliferation, with effects modulated by p53 status.
- The findings suggest a novel feedback mechanism involving Sgk1 and p53 with implications for cancer therapy.
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
